Status:
RECRUITING
Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients
Lead Sponsor:
University of Liege
Conditions:
Kidney Transplant Rejection
Kidney Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The renal biopsy (RB) represents the gold-standard for the diagnosis of acute renal transplant rejection (AR), and allows early verification of a so-called "subclinical" rejection, ie without any clin...
Detailed Description
Subclinical rejection (SCR) has been defined as "the documentation by light histology of unexpected evidence of acute rejection (AR) in a stable patient". The diagnosis of SCR is important given that ...
Eligibility Criteria
Inclusion
- Kidney recipients aged over 18 and of all sexes
Exclusion
- Pregnant patients
- Polyomavirus nephropathy
- Highly sensitised patients (historical or at 3 months Donor specific antibodies)
- No corticosteroids withdrawal allowed (second kidney transplantation or primary disease)
Key Trial Info
Start Date :
January 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04702022
Start Date
January 4 2021
End Date
January 1 2027
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antoine Bouquegneau
Liège, Liège, Belgium, 4000